Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements
Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2022-07-28. On CanQuery you can follow the original downloads. Files are available in English and French.
COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the International Council for Harmonization Q7A guideline and with applicable Health Canada's guidance.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-07-28
Data overview
- Formats
- HTML
- File languages
- English, French